Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Short-term Investments (2022 - 2024)

Oncology Institute (TOI) has disclosed Short-term Investments for 3 consecutive years, with $9.9 million as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Short-term Investments fell 3.42% year-over-year to $9.9 million, compared with a TTM value of $9.9 million through Jun 2024, down 3.42%, and an annual FY2023 reading of $49.4 million, down 17.44% over the prior year.
  • Short-term Investments was $9.9 million for Q2 2024 at Oncology Institute, down from $29.8 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $59.9 million in Q3 2023 and bottomed at $9.9 million in Q2 2024.
  • Average Short-term Investments over 3 years is $36.0 million, with a median of $35.0 million recorded in 2023.
  • The sharpest move saw Short-term Investments surged 105.38% in 2023, then fell 25.8% in 2024.
  • Year by year, Short-term Investments stood at $59.8 million in 2022, then decreased by 17.44% to $49.4 million in 2023, then crashed by 79.87% to $9.9 million in 2024.
  • Business Quant data shows Short-term Investments for TOI at $9.9 million in Q2 2024, $29.8 million in Q1 2024, and $49.4 million in Q4 2023.